Mutation of epidermal growth factor receptor is associated with MIG6 expression
暂无分享,去创建一个
Hiroshi Tanaka | Shih-Feng Tsai | Makoto Taiji | Mariko Hatakeyama | Atsushi Suenaga | Yoshimi Naruo | Takeshi Nagashima | Ryoko Ushikoshi-Nakayama | Yuko Saeki | Kaoru Takahashi | M. Hatakeyama | N. Yumoto | S. Tsai | A. Suenaga | M. Taiji | T. Nagashima | Hiroshi Tanaka | Kaori Ide | Noriko Yumoto | Kaoru Takahashi | K. Ide | Y. Saeki | Yoshimi Naruo | Ryoko Ushikoshi-Nakayama
[1] Benjamin M. Bolstad,et al. affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..
[2] Chen Huiping,et al. Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin , 2005, Oncogene.
[3] G. Sala,et al. Feedback inhibition by RALT controls signal output by the ErbB network , 2003, Oncogene.
[4] I. Dikic,et al. Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation , 2005, EMBO reports.
[5] A. Ullrich,et al. Mig-6 Is a Negative Regulator of the Epidermal Growth Factor Receptor Signal , 2001, Biological chemistry.
[6] E. Nishida,et al. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway , 2002, Nature Cell Biology.
[7] M. Freeman. Feedback control of intercellular signalling in development , 2000, Nature.
[8] A. Citri,et al. EGF–ERBB signalling: towards the systems level , 2006, Nature Reviews Molecular Cell Biology.
[9] Patricia L. Harris,et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.
[10] S. Gabriel,et al. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.
[11] Eytan Domany,et al. A module of negative feedback regulators defines growth factor signaling , 2007, Nature Genetics.
[12] F. Sicheri. Faculty Opinions recommendation of Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. , 2007 .
[13] Y. Sakaki,et al. Phosphoproteome and transcriptome analyses of ErbB ligand-stimulated MCF-7 cells. , 2008, Cancer genomics & proteomics.
[14] Hidetoshi Shimodaira,et al. Pvclust: an R package for assessing the uncertainty in hierarchical clustering , 2006, Bioinform..
[15] O. Segatto,et al. The evolutionarily conserved EBR module of RALT/MIG6 mediates suppression of the EGFR catalytic activity , 2007, Oncogene.
[16] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[17] Rüdiger Klein,et al. Mig6 is a negative regulator of EGF receptor–mediated skin morphogenesis and tumor formation , 2006, Nature Medicine.
[18] N. Hynes,et al. ErbB‐2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling , 1997, The EMBO journal.
[19] H. Kitano,et al. A comprehensive pathway map of epidermal growth factor receptor signaling , 2005, Molecular systems biology.
[20] V. Litvak,et al. Sprouty Fine-Tunes EGF Signaling through Interlinked Positive and Negative Feedback Loops , 2003, Current Biology.
[21] G. Christofori,et al. Modulation of Endocrine Pancreas Development but not β-Cell Carcinogenesis by Sprouty4 , 2008, Molecular Cancer Research.
[22] Boris N. Kholodenko,et al. Untangling the signalling wires , 2007, Nature Cell Biology.
[23] S. Tsai,et al. Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants , 2006, Oncogene.
[24] M. Greene,et al. p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[25] P. Bastiaens,et al. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate , 2007, Nature Cell Biology.
[26] E. Gilles,et al. Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors , 2002, Nature Biotechnology.
[27] Y. Yarden,et al. Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.
[28] M. Crescenzi,et al. Inhibition of ErbB-2 Mitogenic and Transforming Activity by RALT, a Mitogen-Induced Signal Transducer Which Binds to the ErbB-2 Kinase Domain , 2000, Molecular and Cellular Biology.
[29] Shih-Feng Tsai,et al. High Frequency of Epidermal Growth Factor Receptor Mutations with Complex Patterns in Non–Small Cell Lung Cancers Related to Gefitinib Responsiveness in Taiwan , 2004, Clinical Cancer Research.
[30] Yoshihiro Yamanishi,et al. KEGG for linking genomes to life and the environment , 2007, Nucleic Acids Res..